{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T01:59:04Z","timestamp":1787450344302,"version":"build-2736575974"},"reference-count":32,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2015,4,12]]},"published-print":{"date-parts":[[2015,5]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To analyse the effect of biological agents (BAs) in terms of achieving inactive disease (ID) or clinical remission (CR) in patients with systemic juvenile idiopathic arthritis (SJIA), to describe effects of switching or discontinuing a BA and to assess the proportion of patients able to maintain ID or CR off steroids and after withdrawing BA therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Retrospective study in a French paediatric rheumatology reference centre using the CEMARA (CEntre des MAladies RAres) register.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Seventy-seven patients were included with a cumulative follow-up of 245.5 patient-years (median 1.1, range 0.5\u20138.0). On a first BA, ID was achieved in 37 patients, including 1 patient out of 12 patients on etanercept, 26 patients out of 51 on anakinra and 7 out of 10 on canakinumab. One patient on abatacept and two patients on tocilizumab also achieved ID. Switching of BA was common. The switch to a second (n=34), third (n=18) or fourth (n=4) BA resulted in ID in a further 13 patients, either on canakinumab (n=6) or tocilizumab (n=7). At last follow-up, 40 patients were in CR (27 patients off steroids, 5 patients having never received steroid treatment), either on (n=29) or off (n=11) BA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In this series of patients with SJIA, interleukin-1 inhibitors were associated with a higher proportion of ID than tumour necrosis factor inhibitors when used as first BA. Switching allowed some patients to achieve ID when treated with canakinumab or tocilizumab. CR was eventually achieved in more than half of the patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2014-000036","type":"journal-article","created":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T20:12:22Z","timestamp":1430511142000},"page":"e000036","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":47,"title":["Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent"],"prefix":"10.1136","volume":"1","author":[{"given":"A","family":"Woerner","sequence":"first","affiliation":[{"name":"Department of Paediatric Immunology, Hematology and Rheumatology and Institut IMAGINE, H\u00f4pital Necker-Enfants Malades, Assistance Publique H\u00f4pitaux de Paris, Paris, France"},{"name":"Department of Pediatric Rheumatology, University of Basel, University Children's Hospital, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Uettwiller","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology, Hematology and Rheumatology and Institut IMAGINE, H\u00f4pital Necker-Enfants Malades, Assistance Publique H\u00f4pitaux de Paris, Paris, France"},{"name":"Clocheville Hospital, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Melki","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology, Hematology and Rheumatology and Institut IMAGINE, H\u00f4pital Necker-Enfants Malades, Assistance Publique H\u00f4pitaux de Paris, Paris, France"},{"name":"Department of Pediatrics, H\u00f4pital Robert Debr\u00e9, Assistance Publique H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Mouy","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology, Hematology and Rheumatology and Institut IMAGINE, H\u00f4pital Necker-Enfants Malades, Assistance Publique H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Wouters","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology, Hematology and Rheumatology and Institut IMAGINE, H\u00f4pital Necker-Enfants Malades, Assistance Publique H\u00f4pitaux de Paris, Paris, France"},{"name":"Department of Microbiology and Immunology, Pediatric Immunology and Pediatric Rheumatology, KU Leuven-University of Leuven, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Bader-Meunier","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology, Hematology and Rheumatology and Institut IMAGINE, H\u00f4pital Necker-Enfants Malades, Assistance Publique H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Quartier","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology, Hematology and Rheumatology and Institut IMAGINE, H\u00f4pital Necker-Enfants Malades, Assistance Publique H\u00f4pitaux de Paris, Paris, France"},{"name":"Universit\u00e9 Paris-Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,4,30]]},"reference":[{"key":"2025090313541455000_1.1.e000036.1","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"2025090313541455000_1.1.e000036.2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050473"},{"key":"2025090313541455000_1.1.e000036.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2011.68"},{"key":"2025090313541455000_1.1.e000036.4","doi-asserted-by":"publisher","DOI":"10.1002\/art.10885"},{"key":"2025090313541455000_1.1.e000036.5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.014886"},{"key":"2025090313541455000_1.1.e000036.6","doi-asserted-by":"publisher","DOI":"10.1002\/art.38296"},{"key":"2025090313541455000_1.1.e000036.7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.076034"},{"key":"2025090313541455000_1.1.e000036.8","doi-asserted-by":"publisher","DOI":"10.1002\/art.30128"},{"key":"2025090313541455000_1.1.e000036.9","doi-asserted-by":"publisher","DOI":"10.1002\/art.23437"},{"key":"2025090313541455000_1.1.e000036.10","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181a4f459"},{"key":"2025090313541455000_1.1.e000036.11","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.134254"},{"key":"2025090313541455000_1.1.e000036.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205099"},{"key":"2025090313541455000_1.1.e000036.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112802"},{"key":"2025090313541455000_1.1.e000036.14","doi-asserted-by":"publisher","DOI":"10.1002\/art.38042"},{"key":"2025090313541455000_1.1.e000036.15","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20460"},{"key":"2025090313541455000_1.1.e000036.16","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22087"},{"issue":"(Pt 1)","key":"2025090313541455000_1.1.e000036.17","first-page":"481","article-title":"CEMARA an information system for rare diseases","volume":"160","author":"Landais","year":"2010","journal-title":"Stud Health Technol Inform"},{"key":"2025090313541455000_1.1.e000036.18","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20497"},{"key":"2025090313541455000_1.1.e000036.19","doi-asserted-by":"publisher","DOI":"10.1002\/art.21389"},{"key":"2025090313541455000_1.1.e000036.20","first-page":"491","article-title":"Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10\u2005years","volume":"27","author":"Lomater","year":"2000","journal-title":"J Rheumatol"},{"key":"2025090313541455000_1.1.e000036.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1521-6942(02)90233-0"},{"key":"2025090313541455000_1.1.e000036.22","first-page":"935","article-title":"Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis","volume":"32","author":"Kimura","year":"2005","journal-title":"J Rheumatol"},{"key":"2025090313541455000_1.1.e000036.23","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.087411"},{"key":"2025090313541455000_1.1.e000036.24","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.087130"},{"key":"2025090313541455000_1.1.e000036.25","doi-asserted-by":"publisher","DOI":"10.1002\/art.21774"},{"key":"2025090313541455000_1.1.e000036.26","doi-asserted-by":"crossref","unstructured":"Otten MH , Anink J , Prince FHM , et al . Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register. Ann Rheum Dis 2014 Published Online First: 18 Mar 2014. doi: 10.1136\/annrheumdis-2013-204641 doi:10.1136\/annrheumdis-2013-204641","DOI":"10.1136\/annrheumdis-2013-204641"},{"key":"2025090313541455000_1.1.e000036.27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-201060"},{"key":"2025090313541455000_1.1.e000036.28","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130690"},{"key":"2025090313541455000_1.1.e000036.29","doi-asserted-by":"publisher","DOI":"10.1002\/art.38417"},{"key":"2025090313541455000_1.1.e000036.30","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.087593"},{"key":"2025090313541455000_1.1.e000036.31","doi-asserted-by":"publisher","DOI":"10.1002\/art.23427"},{"key":"2025090313541455000_1.1.e000036.32","doi-asserted-by":"publisher","DOI":"10.1002\/art.24516"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2014-000036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:54:24Z","timestamp":1756932864000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2014-000036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,30]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,4,30]]},"published-print":{"date-parts":[[2015,5]]}},"alternative-id":["10.1136\/rmdopen-2014-000036"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2014-000036","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,30]]}}}